Clinical Trial Update: Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating lot consistency of a bivalent HPV vaccine in healthy females aged 9 to 30 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv Infection

Drugs mentioned

• Bivalent HPV Vaccine

Snippet

Sponsor: Shanghai Zerun Biotechnology Co.,Ltd | Conditions: HPV Infection | Phase 3 | Status: COMPLETED